Rigel Pharmaceuticals
RIGL
RIGL
126 hedge funds and large institutions have $234M invested in Rigel Pharmaceuticals in 2020 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 35 increasing their positions, 48 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more ownership
Funds ownership: →
less call options, than puts
Call options by funds: $ | Put options by funds: $
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
27% less repeat investments, than reductions
Existing positions increased: 35 | Existing positions reduced: 48
53% less first-time investments, than exits
New positions opened: 8 | Existing positions closed: 17
Holders
126
Holding in Top 10
–
Calls
$48K
Puts
$51K
Top Buyers
| 1 | +$2.26M | |
| 2 | +$2.19M | |
| 3 | +$2.08M | |
| 4 |
Renaissance Technologies
New York
|
+$1.92M |
| 5 |
CCM
Cadence Capital Management
Boston,
Massachusetts
|
+$1M |
Top Sellers
| 1 | -$1.71M | |
| 2 | -$1.47M | |
| 3 | -$1.39M | |
| 4 |
Two Sigma Investments
New York
|
-$1.25M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$1.24M |